Omega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection

Summary

Omega Laboratories and Cannabix Technologies announced a partnership to develop a breath-based drug testing panel modeled after DOT federally mandated urine drug tests for recent-use detection. The announcement expands breath-testing capabilities for workplace drug screening.